These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21395387)

  • 1. Counselling styles and their effect on subdermal contraceptive implant continuation rates.
    Rubenstein J; Rubenstein P; Barter J; Pittrof R
    Eur J Contracept Reprod Health Care; 2011 Jun; 16(3):225-8. PubMed ID: 21395387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuation rates of the subdermal contraceptive Implanon(®) and associated influencing factors.
    Teunissen AM; Grimm B; Roumen FJ
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):15-21. PubMed ID: 24329119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nexplanon® removals in a community sexual and reproductive health service.
    Chaudhry F
    J Fam Plann Reprod Health Care; 2016 Apr; 42(2):160-1. PubMed ID: 26747656
    [No Abstract]   [Full Text] [Related]  

  • 4. Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting.
    Riney S; O'Shea B; Forde A
    Ir Med J; 2009 Jan; 102(1):24-5. PubMed ID: 19284015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The introduction of a new contraceptive; two years experience with Norplant.
    Davie J; Hiremath K; Glasier A
    Health Bull (Edinb); 1996 Jul; 54(4):314-7. PubMed ID: 8783485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain.
    Arribas-Mir L; Rueda-Lozano D; Agrela-Cardona M; Cedeño-Benavides T; Olvera-Porcel C; Bueno-Cavanillas A
    Contraception; 2009 Nov; 80(5):457-62. PubMed ID: 19835720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital.
    Aisien AO; Enosolease ME
    Niger J Clin Pract; 2010 Sep; 13(3):331-5. PubMed ID: 20857796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference?
    Tocce KM; Sheeder JL; Teal SB
    Am J Obstet Gynecol; 2012 Jun; 206(6):481.e1-7. PubMed ID: 22631865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year assessment of women receiving sub-dermal contraceptive implant at Siriraj Family Planning Clinic.
    Thamkhantho M; Jivasak-Apimas S; Angsuwathana S; Chiravacharadej G; Intawong J
    J Med Assoc Thai; 2008 Jun; 91(6):775-80. PubMed ID: 18697372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia.
    Harvey C; Seib C; Lucke J
    Contraception; 2009 Dec; 80(6):527-32. PubMed ID: 19913146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraceptive implants.
    Ladipo O; Coutinho EM
    Curr Opin Obstet Gynecol; 1994 Dec; 6(6):564-9. PubMed ID: 7893965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implanon. The new alternative.
    Cherry S
    Aust Fam Physician; 2002 Oct; 31(10):897-900. PubMed ID: 12404826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraceptive development and better family planning.
    Segal SJ
    Bull N Y Acad Med; 1996; 73(1):92-104. PubMed ID: 8804742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counseling and management of patients requesting subcutaneous contraceptive implants: proposal for a decisional algorithm.
    Guida M; Visconti F; Cibarelli F; Granozio G; Troisi J; Martini E; Nappi R
    Gynecol Endocrinol; 2014 Jul; 30(7):525-31. PubMed ID: 24720344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding related to etonogestrel subdermal implant in a US population.
    Casey PM; Long ME; Marnach ML; Bury JE
    Contraception; 2011 May; 83(5):426-30. PubMed ID: 21477684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statement on Norplant subdermal contraceptive implant system.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1985 Dec; 19(6):1-3. PubMed ID: 12267509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nexplanon: the new implant for long-term contraception. A comprehensive descriptive review.
    Palomba S; Falbo A; Di Cello A; Materazzo C; Zullo F
    Gynecol Endocrinol; 2012 Sep; 28(9):710-21. PubMed ID: 22339096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience.
    Graesslin O; Korver T
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():4-12. PubMed ID: 18330813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuation rates of Implanon in the UK: data from an observational study in a clinical setting.
    Lakha F; Glasier AF
    Contraception; 2006 Oct; 74(4):287-9. PubMed ID: 16982226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implanon sub-dermal implants: a 10-month review of acceptability in Jos, North-Central Nigeria.
    Mutihir JT; Daru PH
    Niger J Clin Pract; 2008 Dec; 11(4):320-3. PubMed ID: 19320403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.